{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T14:23:11Z","timestamp":1791555791534,"version":"4.3.4"},"reference-count":37,"publisher":"Portland Press Ltd.","issue":"8","license":[{"start":{"date-parts":[[2020,8,21]],"date-time":"2020-08-21T00:00:00Z","timestamp":1597968000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,8,27]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The pathogenesis of cystitis glandular (CG) is unclear, but it is generally considered to be a neoplastic lesion of urothelial hyperplasia formed by long-term chronic stimulation. There is growing evidence that circRNAs play important roles in a variety of cellular processes. However, there are few reports on the role and molecular mechanism of circRNA in CG. In the present study, we first isolated primary cells from CG tissues and adjacent normal tissues. Further experiments showed that CircTHBS1 was up-regulated in primary CG cells (pCGs). The results of CCK-8 showed that the overexpression of CircTHBS1 promoted the viability of pCGs, while the deletion of CircTHBS1 reduced the cell viability. Knocking out CircTHBS1 also inhibited the migration of pCGs. In addition, we demonstrated that CircTHBS1 played a role in the adsorption of miR-211 by \u201csponge\u201d in pCG. In turn, miR-211 can directly target CYCLIN D2 (CCND2) 3\u2032UTR to perform its function. Finally, we confirmed the role and mechanism of CircTHBS1\/miR-211\/CCND2 regulation axis in pCGs. In summary, our study is the first to reveal the role and underlying mechanism of CircTHBS1 in CG, providing a potential biomarker and therapeutic target for human CG.<\/jats:p>","DOI":"10.1042\/bsr20201164","type":"journal-article","created":{"date-parts":[[2020,8,21]],"date-time":"2020-08-21T11:54:11Z","timestamp":1598010851000},"update-policy":"https:\/\/doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["CircTHBS1 targeting miR-211\/CCND2 pathway to promote cell proliferation and migration potential in primary cystitis glandularis cells"],"prefix":"10.1042","volume":"41","author":[{"given":"Yue","family":"Ma","sequence":"first","affiliation":[{"name":"Department of Urology, Mianyang Central Hospital, Mianyang 621000, Sichuan Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengfei","family":"Shan","sequence":"additional","affiliation":[{"name":"Department of Organ Transplantation and Urology, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai 264000, Shandong Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Oncology, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai 264000, Shandong Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honggang","family":"Shao","sequence":"additional","affiliation":[{"name":"Department of Urology, Mianyang Central Hospital, Mianyang 621000, Sichuan Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yupeng","family":"Xin","sequence":"additional","affiliation":[{"name":"Department of Urology, Mianyang Central Hospital, Mianyang 621000, Sichuan Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"He","sequence":"additional","affiliation":[{"name":"Department of Urology, Mianyang Central Hospital, Mianyang 621000, Sichuan Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shichun","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Urology, Mianyang Central Hospital, Mianyang 621000, Sichuan Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4798-0360","authenticated-orcid":false,"given":"Yaodong","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Urology, Mianyang Central Hospital, Mianyang 621000, Sichuan Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"288","published-online":{"date-parts":[[2021,8,12]]},"reference":[{"key":"2021111620263411400_B1","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1097\/00000478-199612000-00005","article-title":"Florid Cystitis Glandularis of Intestinal Type with Mucin Extravasation: A Mimic of Adenocarcinoma","volume":"20","author":"Young","year":"1996","journal-title":"Am. J. Surg. Pathol."},{"key":"2021111620263411400_B2","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s11596-007-0422-5","article-title":"Expression of hTERT, p53 and PCNA in Cystitis Glandularis","volume":"27","author":"Wei","journal-title":"J. Huazhong University Sci. Technol. (Medical Sci.)"},{"key":"2021111620263411400_B3","first-page":"10","article-title":"Cystitis Cystica Glandularis: Radiological Imitator of Urothelial Carcinoma","volume":"12","author":"Sureka","year":"2018","journal-title":"Iran. J. Kidney Dis."},{"key":"2021111620263411400_B4","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1016\/j.juro.2009.03.026","article-title":"Clinical Presentation and Urachal Remnant Pathology: Implications for Treatment","volume":"182","author":"Copp","journal-title":"J. Urol."},{"key":"2021111620263411400_B5","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/S0022-5347(17)66349-3","article-title":"Transition of cystitis glandularis to primary adenocarcinoma of the","volume":"79","author":"Shaw","year":"1958","journal-title":"J. Urol."},{"key":"2021111620263411400_B6","doi-asserted-by":"crossref","first-page":"108872","DOI":"10.1016\/j.biopha.2019.108872","article-title":"UCA1 promotes cell viability, proliferation and migration potential through UCA1\/miR-204\/CCND2 pathway in primary cystitis glandularis cells","volume":"114","author":"Zhou","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"2021111620263411400_B7","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1182\/blood-2018-07-862151","article-title":"CCND2 and CCND3 hijack immunoglobulin light chain enhancers in cyclin D1-negative mantle cell lymphoma","volume":"133","author":"Martin-Garcia","year":"2018","journal-title":"Blood"},{"key":"2021111620263411400_B8","doi-asserted-by":"publisher","first-page":"3096","DOI":"10.3390\/ijms19103096","article-title":"Hypermethylation of CCND2 in Lung and Breast Cancer Is a Potential Biomarker and Drug Target","volume":"19","author":"Hung","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"2021111620263411400_B9","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1002\/cam4.2592","article-title":"Prognostic impact of glioblastoma stem cell markers OLIG2 and CCND2","volume":"9","author":"Bouchart","year":"2019","journal-title":"Cancer Med."},{"key":"2021111620263411400_B10","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0022-5347(17)38342-8","article-title":"Pelvic lipomatosis associated with cystitis glandularis and adenocarcinoma of the bladder","volume":"145","author":"Heyns","year":"1992","journal-title":"J Urol."},{"key":"2021111620263411400_B11","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/S0022-5347(17)60804-8","article-title":"Conversion of Cystitis Glandularis to Adenocarcinoma","volume":"108","author":"Edwards","journal-title":"J. Urol."},{"key":"2021111620263411400_B12","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s10024-002-8817-6","article-title":"Giant Botryoid Fibroepithelial Polyp of Bladder with Myofibroblastic Stroma and Cystitis Cystica et Glandularis","volume":"6","author":"Al-Ahmadie","journal-title":"Pediatr. Dev. Pathol."},{"key":"2021111620263411400_B13","first-page":"734","article-title":"Prostate Specific Antigen and Acid Phosphatase-Reactive Cells in Cystitis Cystica and Glandularis","volume":"112","author":"Nowels","year":"1988","journal-title":"Arch. Pathol. Lab. Med."},{"key":"2021111620263411400_B14","doi-asserted-by":"publisher","first-page":"336","DOI":"10.4236\/oju.2018.812037","article-title":"Cystitis Glandularis: A Rare Benign Condition Presenting as Bladder Tumor","volume":"8","author":"Harrison","year":"2018","journal-title":"Open J. Urol."},{"key":"2021111620263411400_B15","first-page":"3591","article-title":"Changes of bladder mucosal inflammatory factors and prognosis in cystitis glandularis","volume":"11","author":"Qu","year":"2018","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"2021111620263411400_B16","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1002\/dc.20774","article-title":"Cystitis glandularis","volume":"36","author":"Pantanowitz","year":"2008","journal-title":"Diagn. Cytopathol."},{"key":"2021111620263411400_B17","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1038\/s41419-019-1986-2","article-title":"ACT001, a novel PAI-1 inhibitor, exerts synergistic effects in combination with cisplatin by inhibiting PI3K\/AKT pathway in glioma","volume":"10","author":"Xi","year":"2019","journal-title":"Cell Death Dis."},{"key":"2021111620263411400_B18","doi-asserted-by":"crossref","first-page":"64622","DOI":"10.18632\/oncotarget.19930","article-title":"Regulation of microRNAs function by circular RNAs in human cancer","volume":"8","author":"Han","journal-title":"Oncotarget"},{"key":"2021111620263411400_B19","doi-asserted-by":"crossref","first-page":"30919","DOI":"10.1038\/srep30919","article-title":"Screening differential circular RNA expression profiles reveals the regulatory role of circTCF25-miR-103a-3p\/miR-107-CDK6 pathway in bladder carcinoma","volume":"6","author":"Zhong","journal-title":"Sci. Rep."},{"key":"2021111620263411400_B20","doi-asserted-by":"crossref","first-page":"47186","DOI":"10.18632\/oncotarget.9706","article-title":"Comprehensive analysis of differentially expressed profiles of lncRNAs and circRNAs with associated co-expression and ceRNA networks in bladder carcinoma","volume":"7","author":"Huang","journal-title":"Oncotarget"},{"key":"2021111620263411400_B21","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1186\/s13046-019-1291-z","article-title":"6-Gingerol stabilized the p-VEGFR2\/VE-cadherin\/beta-catenin\/actin complex promotes microvessel normalization and suppresses tumor progression","volume":"38","author":"Zhong","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"2021111620263411400_B22","first-page":"1156","article-title":"Proinflammatory cytokines decrease the expression of genes critical for RPE function","volume":"22","author":"Kutty","year":"2016","journal-title":"Mol. Vis."},{"key":"2021111620263411400_B23","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1186\/s12885-016-2784-1","article-title":"Polymorphisms in miR-135a-2, miR-219-2 and miR-211 as well as their interaction with cooking oil fume exposure on the risk of lung cancer in Chinese nonsmoking females: a case\u2013control study","volume":"16","author":"Yin","year":"2016","journal-title":"BMC Cancer"},{"key":"2021111620263411400_B24","first-page":"0008","article-title":"MicroRNA-211 enhances the oncogenicity of carcinogen-induced oral carcinoma by repressing TCF12 and increasing antioxidant activity","volume":"76","author":"Chen","journal-title":"Cancer Res."},{"key":"2021111620263411400_B25","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.omtn.2019.02.017","article-title":"lncRNA TUG1 Promotes Cisplatin Resistance by Regulating CCND2 via Epigenetically Silencing miR-194-5p in Bladder Cancer","volume":"16","author":"Yu","year":"2019","journal-title":"Mol. Ther. \u2014 Nucleic Acids"},{"key":"2021111620263411400_B26","doi-asserted-by":"publisher","first-page":"9324","DOI":"10.1002\/jcb.28208","article-title":"Long noncoding RNA FOXD2-AS1 promotes glioma malignancy and tumorigenesis via targeting miR - 185 - 5p\/CCND2 axis","volume":"120","author":"Shen","year":"2019","journal-title":"J. Cell. Biochem."},{"key":"2021111620263411400_B27","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.3892\/ol.2015.3541","article-title":"microRNA-195 inhibits the proliferation, migration and invasion of cervical cancer cells via the inhibition of CCND2 and MYB expression","volume":"10","author":"Du","year":"2015","journal-title":"Oncol. Lett."},{"key":"2021111620263411400_B28","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.biopha.2014.12.037","article-title":"Prognostic significance of combined microRNA-206 and CyclinD2 in gastric cancer patients after curative surgery: A retrospective cohort study","volume":"71","author":"Shi","journal-title":"Biomed. Pharmacother."},{"key":"2021111620263411400_B29","doi-asserted-by":"crossref","first-page":"59287","DOI":"10.18632\/oncotarget.11040","article-title":"MiR-146a-5p inhibits cell proliferation and cell cycle progression in NSCLC cell lines by targeting CCND1 and CCND2","volume":"7","author":"Li","journal-title":"Oncotarget"},{"key":"2021111620263411400_B30","doi-asserted-by":"crossref","first-page":"4538","DOI":"10.1038\/s41598-017-04731-4","article-title":"Genetic association analysis of the RTK\/ERK pathway with aggressive prostate cancer highlights the potential role of CCND2 in disease progression","volume":"7","author":"Chen","journal-title":"Sci. Rep."},{"key":"2021111620263411400_B31","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.ebiom.2018.10.041","article-title":"Salvianolic acid A targeting the transgelin-actin complex to enhance vasoconstriction","volume":"37","author":"Zhong","year":"2018","journal-title":"EBioMedicine"},{"key":"2021111620263411400_B32","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1089\/dna.2017.3829","article-title":"MicroRNA-1297 Inhibits the Growth and Metastasis of Colorectal Cancer by Suppressing Cyclin D2 Expression","volume":"36","author":"Wang","year":"2017","journal-title":"DNA Cell Biol."},{"key":"2021111620263411400_B33","first-page":"1","article-title":"LncRNA GACAT3 predicts poor prognosis and promotes cell proliferation in breast cancer through regulation of miR-497\/CCND2","volume-title":"Cancer Biomark","author":"Hua"},{"key":"2021111620263411400_B34","first-page":"374","article-title":"Expression and clinical significance of Notch signalingrelated proteins in cystitis glandularis and bladder cancer","volume":"30","author":"Zhuangcheng","year":"2018","journal-title":"Carcinogenesis Teratogenesis Mutagenesis"},{"key":"2021111620263411400_B35","first-page":"2407","article-title":"miR-671-3p is downregulated in non-small cell lung cancer and inhibits cancer progression by directly targeting CCND2","volume":"19","author":"Yao","year":"2019","journal-title":"Mol. Med. Rep."},{"key":"2021111620263411400_B36","first-page":"32","article-title":"Effect of Magui Liquid on Transforming Growth Factor-\u03b21 and Epidermal Growth Factor-\u03b2 in a Rat Model of Glandular Cystitis","volume":"38","author":"Wei","year":"2018","journal-title":"J. Hunan University of Chinese Med."},{"key":"2021111620263411400_B37","doi-asserted-by":"crossref","first-page":"4360","DOI":"10.1002\/cam4.3062","article-title":"MiR6 suppresses proliferation and metastasis of non-small cell lung cancer by repressing FGF2 and CCND2","volume":"9","author":"Wang","year":"2020","journal-title":"Cancer Med."}],"container-title":["Bioscience Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/portlandpress.com\/bioscirep\/article-pdf\/doi\/10.1042\/BSR20201164\/918815\/bsr-2020-1164.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/portlandpress.com\/bioscirep\/article-pdf\/doi\/10.1042\/BSR20201164\/918815\/bsr-2020-1164.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T20:55:20Z","timestamp":1637096120000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/bioscirep\/article\/41\/8\/BSR20201164\/226170\/CircTHBS1-targeting-miR-211-CCND2-pathway-to"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":37,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8,27]]}},"URL":"https:\/\/doi.org\/10.1042\/bsr20201164","relation":{},"ISSN":["0144-8463","1573-4935"],"issn-type":[{"value":"0144-8463","type":"print"},{"value":"1573-4935","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,8]]},"published":{"date-parts":[[2021,8]]},"article-number":"BSR20201164"}}